Controlled, on-demand release of bioactive molecules is a cornerstone of modern targeted drug delivery and prodrug design. Achieving precise, site-specific activation helps minimize systemic side effects, improve pharmacokinetics, and ultimately enhance therapeutic efficacy.

The trimethyl lock (TML) is a well-established molecular release strategy that exploits sterically accelerated intramolecular lactonization of ortho-hydroxy dihydrocinnamic acid derivatives. In its protected form—when the phenolic hydroxyl group is masked—the system remains stable and cyclization is effectively suppressed.

Upon exposure to a defined chemical or enzymatic trigger (for example, enzymatic cleavage that liberates the free phenolic hydroxyl group), reactivity is restored. This switch initiates rapid lactonization, resulting in efficient and predictable release of the attached payload.

Thanks to its fast kinetics and high modularity, the TML concept has been successfully applied across multiple fields, including:

• Prodrug and targeted drug delivery systems

• Cellular imaging agents and molecular probes

• Stimuli-responsive and smart materials

At SigutLabs, we support the design and synthesis of advanced molecular systems, with a particular focus on stimulus-responsive linkers and prodrug-enabling chemistries.

If you are exploring TML-based release mechanisms or related strategies for your R&D program, we would be happy to discuss how we can support your work—get in touch with us.